Skip to main content

Kodiak Sciences Inc

For the period ended Sep 30, 2024. Filed Nov 14, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 14, 2024

KOD$108.06+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity

Common Stock · AdditionalPaid-In · AccumulatedOtherComprehensive · Accumulated · TotalStockholders’
SharesAmountCapitalIncome (Loss)DeficitEquity
Balances at December 31, 202352,508,602$5$1,418,307$—$(1,152,531)$265,781
Issuance of common stock upon exercise of stock options8,333—38——38
Issuance of common stock upon vesting of restricted stock units6,512—————
Stock-based compensation expense——18,409——18,409
Net loss————(43,039)(43,039)
Balances at March 31, 202452,523,44751,436,754—(1,195,570)241,189
Issuance of common stock upon vesting of restricted stock units64,476—————
Issuance of common stock pursuant to employee stock purchase plan26,806—59——59
Stock-based compensation expense——18,375——18,375
Net loss————(45,117)(45,117)
Balances at June 30, 202452,614,72951,455,188—(1,240,687)214,506
Issuance of common stock upon vesting of restricted stock units8,358—————
Stock-based compensation expense——14,810——14,810
Net loss————(43,946)(43,946)
Balances at September 30, 202452,623,087$5$1,469,998$—$(1,284,633)$185,370
Common Stock · AdditionalPaid-In · AccumulatedOtherComprehensive · Accumulated · TotalStockholders’
SharesAmountCapitalIncome (Loss)DeficitEquity
Balances at December 31, 202252,333,850$5$1,329,509$(1,307)$(892,040)$436,167
Issuance of common stock upon exercise of stock options1,098—9——9
Issuance of common stock upon vesting of restricted stock units9,793—————
Stock-based compensation expense——25,980——25,980
Other comprehensive income———1,211—1,211
Net loss————(70,780)(70,780)
Balances at March 31, 202352,344,74151,355,498(96)(962,820)392,587
Issuance of common stock upon exercise of stock options6,430—51——51
Issuance of common stock upon vesting of restricted stock units76,152—————
Issuance of common stock pursuant to employee stock purchase plan25,840—131——131
Stock-based compensation expense——25,801——25,801
Other comprehensive income———96—96
Net loss————(80,188)(80,188)
Balances at June 30, 202352,453,16351,381,481—(1,043,008)338,478
Issuance of common stock upon vesting of restricted stock units14,128—————
Stock-based compensation expense——13,946——13,946
Net loss————(50,007)(50,007)
Balances at September 30, 202352,467,291$5$1,395,427$—$(1,093,015)$302,417
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.